These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 21938479)

  • 21. Activity of the delta-opioid receptor is partially reduced, whereas activity of the kappa-receptor is maintained in mice lacking the mu-receptor.
    Matthes HW; Smadja C; Valverde O; Vonesch JL; Foutz AS; Boudinot E; Denavit-Saubié M; Severini C; Negri L; Roques BP; Maldonado R; Kieffer BL
    J Neurosci; 1998 Sep; 18(18):7285-95. PubMed ID: 9736649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mice deficient for delta- and mu-opioid receptors exhibit opposing alterations of emotional responses.
    Filliol D; Ghozland S; Chluba J; Martin M; Matthes HW; Simonin F; Befort K; Gavériaux-Ruff C; Dierich A; LeMeur M; Valverde O; Maldonado R; Kieffer BL
    Nat Genet; 2000 Jun; 25(2):195-200. PubMed ID: 10835636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of [3H]bremazocine binding in single and combinatorial opioid receptor knockout mice.
    Simonin F; Slowe S; Becker JA; Matthes HW; Filliol D; Chluba J; Kitchen I; Kieffer BL
    Eur J Pharmacol; 2001 Mar; 414(2-3):189-95. PubMed ID: 11239918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Motivational effects of cannabinoids are mediated by mu-opioid and kappa-opioid receptors.
    Ghozland S; Matthes HW; Simonin F; Filliol D; Kieffer BL; Maldonado R
    J Neurosci; 2002 Feb; 22(3):1146-54. PubMed ID: 11826143
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of G-protein activation in the brain by mu-, delta-, and kappa-opioid receptor agonists in mu-opioid receptor knockout mice.
    Park Y; Ma T; Tanaka S; Jang C; Loh HH; Ko KH; Ho IK
    Brain Res Bull; 2000 Jul; 52(4):297-302. PubMed ID: 10856828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
    Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M
    Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Opposite alterations of NPFF1 and NPFF2 neuropeptide FF receptor density in the triple MOR/DOR/KOR-opioid receptor knockout mouse brains.
    Gouardères C; Kieffer BL; Zajac JM
    J Chem Neuroanat; 2004 May; 27(2):119-28. PubMed ID: 15121216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD4+ Th2 cells function alike effector Tr1 and Th1 cells through the deletion of a single cytokine IL-6 and IL-10 gene.
    Ankathatti Munegowda M; Xu S; Freywald A; Xiang J
    Mol Immunol; 2012 Jun; 51(2):143-9. PubMed ID: 22424785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improgan, a cimetidine analog, induces morphine-like antinociception in opioid receptor-knockout mice.
    Hough LB; Nalwalk JW; Chen Y; Schuller A; Zhu Y; Zhang J; Menge WM; Leurs R; Timmerman H; Pintar JE
    Brain Res; 2000 Oct; 880(1-2):102-8. PubMed ID: 11032994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of hypothalamic-pituitary axis in morphine-induced alteration in thymic cell distribution using mu-opioid receptor knockout mice.
    Roy S; Wang JH; Balasubramanian S; Sumandeep ; Charboneau R; Barke R; Loh HH
    J Neuroimmunol; 2001 Jun; 116(2):147-55. PubMed ID: 11438169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Naloxone fails to produce conditioned place aversion in mu-opioid receptor knock-out mice.
    Skoubis PD; Matthes HW; Walwyn WM; Kieffer BL; Maidment NT
    Neuroscience; 2001; 106(4):757-63. PubMed ID: 11682161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of opioid peptides on immunomodulation].
    Cheĭdo MA; Idova GV
    Ross Fiziol Zh Im I M Sechenova; 1998 Apr; 84(4):385-90. PubMed ID: 9742618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Opioid receptor gene expression in dopamine transporter knock-out mice in adult and during development.
    Le Moine C; Fauchey V; Jaber M
    Neuroscience; 2002; 112(1):131-9. PubMed ID: 12044478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retinoic acids exert direct effects on T cells to suppress Th1 development and enhance Th2 development via retinoic acid receptors.
    Iwata M; Eshima Y; Kagechika H
    Int Immunol; 2003 Aug; 15(8):1017-25. PubMed ID: 12882839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression and function of CTLA-4 in Th1 and Th2 cells.
    Alegre ML; Shiels H; Thompson CB; Gajewski TF
    J Immunol; 1998 Oct; 161(7):3347-56. PubMed ID: 9759851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. No evidence for G-protein-coupled epsilon receptor in the brain of triple opioid receptor knockout mouse.
    Contet C; Matifas A; Kieffer BL
    Eur J Pharmacol; 2004 May; 492(2-3):131-6. PubMed ID: 15178356
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mu and delta opioid receptor knockout mice show increased colonic sensitivity.
    Reiss D; Ceredig RA; Secher T; Boué J; Barreau F; Dietrich G; Gavériaux-Ruff C
    Eur J Pain; 2017 Apr; 21(4):623-634. PubMed ID: 27748566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Single cell analysis reveals that IL-4 receptor/Stat6 signaling is not required for the in vivo or in vitro development of CD4+ lymphocytes with a Th2 cytokine profile.
    Jankovic D; Kullberg MC; Noben-Trauth N; Caspar P; Paul WE; Sher A
    J Immunol; 2000 Mar; 164(6):3047-55. PubMed ID: 10706693
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Buprenorphine antinociception is abolished, but naloxone-sensitive reward is retained, in mu-opioid receptor knockout mice.
    Ide S; Minami M; Satoh M; Uhl GR; Sora I; Ikeda K
    Neuropsychopharmacology; 2004 Sep; 29(9):1656-63. PubMed ID: 15100703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methionine-enkephalin stimulates hydrogen peroxide and nitric oxide production in rat peritoneal macrophages: interaction of mu, delta and kappa opioid receptors.
    Vujić V; Stanojević S; Dimitrijević M
    Neuroimmunomodulation; 2004; 11(6):392-403. PubMed ID: 15467355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.